Single center experience of 90Y-Ibritumomab tiuxetan in the older population with non-hodgkin lymphoma.

被引：0
作者：
Agrawal, Vaibhav [1 ]
Castillo, Jose Isaac [1 ]
Raup, Kelly [1 ]
Girton, Treanna [1 ]
Collins, Scott R. [1 ]
Brady, James O. [1 ]
Khan, Sharif S. [1 ]
Vadakara, Joseph [1 ]
机构：
[1] Geisinger Med Ctr, Danville, PA 17822 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.e19035
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19035
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Phase I trial of combination therapy with 90Y ibritumomab tiuxetan and gemcitabine in patients with non-Hodgkin is lymphoma.
    Borghaei, Hossein
    Smith, Mitchell
    Millenson, Michael
    Shafer, Danielle
    Thibodeau, Linda
    Schilder, Russell
    BLOOD, 2006, 108 (11) : 260B - 260B
  • [22] Therapy with 90Y Ibritumomab tiuxetan in Relapsed/Refractory Non-Hodgkin Lymphoma. Analysis of recent outcomes.
    Baringo, T.
    Lievano, P.
    Navarro, P.
    Arroyo, E.
    Ananos, M.
    De la Cueva, L.
    Gonzalez, M.
    Abos, M.
    Giraldo, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S419 - S419
  • [23] Safety and efficacy of external beam radiation therapy for non-Hodgkin lymphoma in patients with prior 90Y-ibritumomab tiuxetan radioimmunotherapy
    Justice, Terry E.
    Martenson, James A.
    Wiseman, Gregory A.
    Witzig, Thomas E.
    CANCER, 2006, 107 (02) : 433 - 438
  • [24] Impact of Rituximab Treatment on 90Y-Ibritumomab Dosimetry for Patients with Non-Hodgkin Lymphoma
    Shen, Sui
    Forero, Andres
    Meredith, Ruby F.
    Shah, Jatin J.
    Knox, Susan J.
    Wiseman, Gregory A.
    Usrey, Marc E.
    LoBuglio, Albert F.
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (01) : 150 - 157
  • [25] Radioimmun therapy with (90)Y-Ibritumomab tiuxetan in patients with non-hodgkin's lymphoma
    Kaya, H.
    Ayyildiz, O.
    Altunci, G. Kaya
    Bellur, B. Kizilkan
    Isikdogan, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S420 - S420
  • [26] Yttrium-90 ibritumomab tiuxetan in the treatment of non-Hodgkin lymphoma
    McKinney, Matthew S.
    Beaven, Anne W.
    BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY, 2014, 4 : 45 - 59
  • [27] Ibritumomab tiuxetan for non-Hodgkin's lymphoma
    Johnston, Patrick B.
    Bondly, Cara
    Micallef, Ivana N. M.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (06) : 861 - 869
  • [28] Assessment of Metabolic Response to Radioimmunotherapy with 90Y-Ibritumomab Tiuxetan in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
    Storto, Giovanni
    De Renzo, Amalia
    Pellegrino, Teresa
    Perna, Fabiana
    De Falco, Teresa
    Erra, Paola
    Nardelli, Anna
    Speranza, Antonio
    Klain, Michele
    Rotoli, Bruno
    Pace, Leonardo
    RADIOLOGY, 2010, 254 (01) : 245 - 252
  • [29] Radioimmunotherapy with 90Y ibritumomab tiuxetan in refractory/relapsed follicular non-hodgkin lymphoma results in an Spanish center
    Rubio-Martinez, A.
    Agustin, M. J.
    Recasens, V.
    Lopez-Gomez, L.
    Perella, M.
    Perez-Lungmus, G.
    Baringo, T.
    Giraldo, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 418 - 418
  • [30] Timing between rituximab and 90Y-ibritumomab tiuxetan in pts with Non-Hodgkin's lymphoma does not affect clinical outcomes.
    Friedman, Isaiah E.
    Andreadis, Charalambos
    Diangi, Yumi Taylor
    Nasta, Sunita D.
    Luger, Selina M.
    Stadtmauer, Edward A.
    Schuster, Stephen J.
    BLOOD, 2006, 108 (11) : 267B - 267B
12345